Skip to content
Medical Health Aged Care

Participants needed for trial of promising treatment for progressive supranuclear palsy (PSP)

Monash University 2 mins read

In a first for Monash University and The Alfred, researchers have received an orphan drug designation by the European Medicines Agency (EMA) for sodium selenate in the treatment of progressive supranuclear palsy (PSP), and are needing patients with the debilitating disease to test the drug. 

 

PSP is a rare neurological condition that affects walking, balance, eye movements and swallowing, and is caused by a protein build-up in the brain called tau.

 

The phase 2 randomised controlled clinical trial uses sodium selenate as a world first initiative as a disease modifying treatment for PSP, and involves patients having a PET scan to measure tau in their brain. 

 

Received from the European Medicines Agency, orphan drug designation is granted when a drug shows promise in the treatment of a rare disease, and sodium selenate has shown promise in clearing tau build-up in preclinical testing. 

 

PSP is often misdiagnosed as Parkinson's disease, and currently there is no cure, or any specific treatments available. PSP is a fatal illness, with current survival rates ranging from five to eight years from the onset of symptoms.  

 

Lead researcher Dr Lucy Vivash, from Monash University’s Department of Neuroscience, and The Alfred’s Department of Neurology, said this clinical trial is among the few worldwide focusing on this disease. 

 

“The trial is investigating whether our drug, sodium selenate, reduces disease progression in patients with PSP,” Dr Vivash said. 

 

“There are currently no treatments that alter the underlying cause of PSP, accumulation of the toxic protein tau. Our drug acts to prevent or even reverse the build up of this protein, which we hope will halt the progression of symptoms in participants treated with the drug. Given this is a rare disease, new treatments, and treatment trials are rare, we need participants in order to find a treatment and one day a cure. 

 

“Beyond investigating the drug, we also hope to be able to use the data collected in this study to better understand PSP, to improve diagnosis as well as identifying potential new treatment targets.” 

 

Ramila, a former kindergarten teacher and participant in the study said, “the care and support I receive from the trial staff is amazing.”

 

“I have enjoyed the social interaction and meeting new people.” 

 

The trial needs participants, (aged 40 years or over), who have been medically diagnosed with PSP. The trial is being run at six participating locations in Melbourne, Brisbane, Sydney and Adelaide.

Those interested in participating in the trial can apply as per below.

 

Email: selenate@alfred.org.au

For more information regarding the trial, visit the ANZCTR website - ACTRN12620001254987

 

-ENDS-

 

MEDIA ENQUIRIES

Monash University
T: +61 3 9903 4840   E: media@monash.edu 

For more Monash media stories visit our news & events site: monash.edu/news

For other expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or media@monash.edu

More from this category

  • Medical Health Aged Care
  • 23/05/2024
  • 13:13
Dementia Australia

ONE WEEK TO GO until the Redcliffe Memory Walk & Jog!

With only a few sleeps to go walkers, joggers and runners are gearing up to participate in the 2024 Redcliffe Memory Walk & Jog. More than 520 people have already signed-up to take part – but there’s always room for more with online registrations still open, or sign-up on the day of the event. Dementia Australia Executive Director Services, Advocacy & Research Dr Kaele Stokes, said it is fantastic to see Redcliffe locals throwing their support behind Memory Walk & Jog. “As we prepare to host Memory Walk & Jog on Saturday 1 June at Scarborough Beach Park, Redcliffe for…

  • Contains:
  • Medical Health Aged Care
  • 23/05/2024
  • 11:26
Royal Australian College of GPs

“No patients should miss out”: GPs call for urgent action on payroll tax hit

The Royal Australia College of GPs (RACGP) is calling on all state and territory governments to save the future of general practice care so that no patients miss out. It comes ahead of the College’s annual Practice Owner’s National Conference in Cairns running 24 to 26 May. This year’s conference includes a presentation entitled Empowering Practices Through Payroll Tax: Reflecting, Positioning, and Advancing. Conducted by Senior Associate Ben Ryan and former RACGP Vice President and Queensland Chair, DrBruceWillett, the session focusses on the challenges posed by this payroll tax hit, the achievements of the College so far fighting for a…

  • Medical Health Aged Care
  • 23/05/2024
  • 11:17
Dementia Australia

On this weekend – Brisbane Memory Walk & Jog

The 2024 Brisbane Memory Walk & Jog is upon us, with the much-anticipated event taking place this weekend on Sunday 26 May at Rocks Riverside Park, Seventeen Mile Rocks. Starting at 7.30am, we welcome everyone in the Brisbane community to join fellow participants as they walk, jog or run to help raise money in support of people living with dementia. Special guests, Dementia Australia Ambassador Wally Lewis AM will be in attendance alongside this year’s MC Dementia Australia Ambassador Takaya Honda. Registrations for the Brisbane Memory Walk & Jog are still open and we would love to see as many…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.